L

Locana, Inc.

68 employees

Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Therapeutics

Date founded

2016

Funding rounds raised

Total raised

$100M

from 15 investors over 15 rounds

L

Locana, Inc. raised $100M on December 14, 2020

Investors: Acuta Capital, UCB Ventures, Lightstone Ventures, The Invus Group, SVB Securities, GV, Vida Ventures, LLC, ARCH Venture Partners, Temasek and RA Capital Management, L.P.

L

Locana, Inc. raised $55M on May 22, 2019

Investors: UCB Ventures, GV, Lightstone Ventures, Temasek and ARCH Venture Partners